Literature DB >> 33441644

On the information hidden in a classifier distribution.

Farrokh Habibzadeh1, Parham Habibzadeh2, Mahboobeh Yadollahie3, Hooman Roozbehi4.   

Abstract

Classification tasks are a common challenge to every field of science. To correctly interpret the results provided by a classifier, we need to know the performance indices of the classifier including its sensitivity, specificity, the most appropriate cut-off value (for continuous classifiers), etc. Typically, several studies should be conducted to find all these indices. Herein, we show that they already exist, hidden in the distribution of the variable used to classify, and can readily be harvested. An educated guess about the distribution of the variable used to classify in each class would help us to decompose the frequency distribution of the variable in population into its components-the probability density function of the variable in each class. Based on the harvested parameters, we can then calculate the performance indices of the classifier. As a case study, we applied the technique to the relative frequency distribution of prostate-specific antigen, a biomarker commonly used in medicine for the diagnosis of prostate cancer. We used nonlinear curve fitting to decompose the variable relative frequency distribution into the probability density functions of the non-diseased and diseased people. The functions were then used to determine the performance indices of the classifier. Sensitivity, specificity, the most appropriate cut-off value, and likelihood ratios were calculated. The reference range of the biomarker and the prevalence of prostate cancer for various age groups were also calculated. The indices obtained were in good agreement with the values reported in previous studies. All these were done without being aware of the real health status of the individuals studied. The method is even applicable for conditions with no definite definitions (e.g., hypertension). We believe the method has a wide range of applications in many scientific fields.

Entities:  

Year:  2021        PMID: 33441644      PMCID: PMC7807039          DOI: 10.1038/s41598-020-79548-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  25 in total

1.  Integrating the predictiveness of a marker with its performance as a classifier.

Authors:  Margaret S Pepe; Ziding Feng; Ying Huang; Gary Longton; Ross Prentice; Ian M Thompson; Yingye Zheng
Journal:  Am J Epidemiol       Date:  2007-11-02       Impact factor: 4.897

2.  Evidence of independent origin of multiple tumors from patients with prostate cancer.

Authors:  L Cheng; S Y Song; T G Pretlow; F W Abdul-Karim; H J Kung; D V Dawson; W S Park; Y W Moon; M L Tsai; W M Linehan; M R Emmert-Buck; L A Liotta; Z Zhuang
Journal:  J Natl Cancer Inst       Date:  1998-02-04       Impact factor: 13.506

Review 3.  Temporal trends and racial disparities in global prostate cancer prevalence.

Authors:  Timothy R Rebbeck; Gabriel P Haas
Journal:  Can J Urol       Date:  2014-10       Impact factor: 1.344

4.  Population standards of prostate specific antigen values in men over 40: community based study in Turkey.

Authors:  Talha Müezzinoğlu; Murat Lekili; Erhan Eser; Bekir S Uyanik; Coşkun Büyüksu
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

5.  Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.

Authors:  J E Oesterling; S J Jacobsen; C G Chute; H A Guess; C J Girman; L A Panser; M M Lieber
Journal:  JAMA       Date:  1993-08-18       Impact factor: 56.272

Review 6.  Prostate Cancer Screening: Shared Decision-Making for Screening and Treatment.

Authors:  Russ Blackwelder; Alexander Chessman
Journal:  Prim Care       Date:  2018-12-24       Impact factor: 2.907

7.  Age-specific prostate-specific antigen reference ranges in Korean men.

Authors:  Young Deuk Choi; Dae Ryong Kang; Chung Mo Nam; Young Sig Kim; Soung Yong Cho; Se Joong Kim; In Rae Cho; Jin Seon Cho; Sung Joon Hong; Won Sik Ham
Journal:  Urology       Date:  2007-12       Impact factor: 2.649

Review 8.  The likelihood ratio and its graphical representation.

Authors:  Farrokh Habibzadeh; Parham Habibzadeh
Journal:  Biochem Med (Zagreb)       Date:  2019-04-15       Impact factor: 2.313

9.  Establishment of reference intervals for serum [-2]proPSA (p2PSA), %p2PSA and prostate health index in healthy men.

Authors:  Zhi-Yu Wu; Cheng Yang; Jie Luo; Shao-Li Deng; Bin Wu; Ming Chen
Journal:  Onco Targets Ther       Date:  2019-08-13       Impact factor: 4.147

Review 10.  The Clinical Relevance of Methods for Handling Inconclusive Medical Test Results: Quantification of Uncertainty in Medical Decision-Making and Screening.

Authors:  Johannes A Landsheer
Journal:  Diagnostics (Basel)       Date:  2018-05-09
View more
  3 in total

Review 1.  The apparent prevalence, the true prevalence.

Authors:  Farrokh Habibzadeh; Parham Habibzadeh; Mahboobeh Yadollahie
Journal:  Biochem Med (Zagreb)       Date:  2022-06-15       Impact factor: 2.515

2.  Determining the SARS-CoV-2 serological immunoassay test performance indices based on the test results frequency distribution.

Authors:  Farrokh Habibzadeh; Parham Habibzadeh; Mahboobeh Yadollahie; Mohammad M Sajadi
Journal:  Biochem Med (Zagreb)       Date:  2022-06-15       Impact factor: 2.515

3.  Molecular diagnostic assays for COVID-19: an overview.

Authors:  Parham Habibzadeh; Mohammad Mofatteh; Mohammad Silawi; Saeid Ghavami; Mohammad Ali Faghihi
Journal:  Crit Rev Clin Lab Sci       Date:  2021-02-17       Impact factor: 6.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.